X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (14) 14
humans (14) 14
breast cancer (11) 11
breast neoplasms - drug therapy (11) 11
index medicus (11) 11
adult (10) 10
disease-free survival (10) 10
middle aged (10) 10
breast neoplasms - pathology (9) 9
chemotherapy (9) 9
hematology, oncology and palliative medicine (9) 9
oncology (9) 9
treatment outcome (9) 9
chemotherapy, adjuvant (8) 8
follow-up studies (8) 8
aged (7) 7
breast neoplasms - mortality (7) 7
trastuzumab (7) 7
therapy (6) 6
cancer therapies (5) 5
drug administration schedule (5) 5
surgery (5) 5
antibodies, monoclonal, humanized - adverse effects (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomarkers, tumor - analysis (4) 4
breast neoplasms - chemistry (4) 4
cancer (4) 4
drug therapy (4) 4
internal medicine (4) 4
medicine, general & internal (4) 4
radiation therapy (4) 4
abridged index medicus (3) 3
administration, oral (3) 3
analysis (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
breast neoplasms - metabolism (3) 3
breast neoplasms - surgery (3) 3
clinical trials (3) 3
combined modality therapy (3) 3
diseases (3) 3
kaplan-meier estimate (3) 3
neoplasm staging (3) 3
postmenopausal women (3) 3
research (3) 3
risk factors (3) 3
survival analysis (3) 3
tamoxifen (3) 3
womens health (3) 3
1st-line treatment (2) 2
adjuvant chemotherapy (2) 2
adjuvant treatment (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents, hormonal - adverse effects (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
aromatase inhibitors - administration & dosage (2) 2
article (2) 2
australia (2) 2
breast neoplasms - therapy (2) 2
care and treatment (2) 2
china (2) 2
china foreign relations (2) 2
china history (2) 2
clinical-trials (2) 2
dose-response relationship, drug (2) 2
double-blind method (2) 2
efficacy (2) 2
endocrine therapy (2) 2
erbb-2 protein (2) 2
europe (2) 2
foreign relations (2) 2
heart diseases - chemically induced (2) 2
history (2) 2
infusions, intravenous (2) 2
international relations (2) 2
internationale betrekkingen (2) 2
lymphatic metastasis (2) 2
mammography (2) 2
medical colleges (2) 2
medical research (2) 2
metastases (2) 2
neoadjuvant therapy (2) 2
neoplasm invasiveness - pathology (2) 2
nitriles - administration & dosage (2) 2
north america (2) 2
patients (2) 2
phase-ii (2) 2
plus (2) 2
postmenopause (2) 2
product development (2) 2
proportional hazards models (2) 2
quinazolines - adverse effects (2) 2
receptor, erbb-2 - analysis (2) 2
receptor, erbb-2 - metabolism (2) 2
recurrence (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | ERBB2 | INHIBITOR | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Medical research | Ligands | Cytotoxicity | Mammography | Kinases | Cancer therapies | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Surgery | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | Diarrhea | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 297 - 305
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1137 - 1146
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1101 - 1108
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 156 - 163
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 848 - 858
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 2, pp. 273 - 279
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article